Damien Dietrich

Adding cetuximab to capecitabine plus oxaliplatin (XELOX) in first-line treatment of metastatic colorectal cancer: a randomized phase II trial of the Swiss Group for Clinical Cancer Research SAKK

Markus Borner, Dieter Koeberle, Roger von Moos et al. · Annals of Oncology · 2008 · 127 citations · Full text

Medicine, Oncology, Pharmacology +10

Adjuvant therapy after excision and radiation of isolated postmastectomy locoregional breast cancer recurrence: definitive results of a phase III randomized trial (SAKK 23/82) comparing tamoxifen with observation

Magdalena Waeber, Monica Castiglione‐Gertsch, Damien Dietrich et al. · Annals of Oncology · 2003 · 104 citations · Full text

Medicine, Oncology, Surgery +17

A randomized phase II trial of capecitabine and two different schedules of irinotecan in first-line treatment of metastatic colorectal cancer: efficacy, quality-of-life and toxicity

Markus Borner, J. Bernhard, Damien Dietrich et al. · Annals of Oncology · 2005 · 103 citations · Full text

Medicine, Oncology, Pharmacology +13

iCHECK-DH: Guidelines and Checklist for the Reporting on Digital Health Implementations

Caroline Perrin, Awa Babington‐Ashaye, Damien Dietrich et al. · Journal of Medical Internet Research · 2023 · 95 citations · Full text

Public Affairs, Health Administration, Health Informatics +16

Microsatellite instability (MSI) in stage II and III colon cancer treated with 5FU-LV or 5FU-LV and irinotecan (PETACC 3-EORTC 40993-SAKK 60/00 trial)

Sabine Tejpar, Fred T. Bosman, Mauro Delorenzi et al. · Journal of Clinical Oncology · 2009 · 92 citations

Medicine, Oncology, Surgery +17